SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Bostwick DG, Burke HB, Djakiew D, et al. Human prostate cancer risk factors. Cancer. 2004; 101(10 suppl ): 23712490.
  • 2
    Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst. 2002; 94: 981990.
  • 3
    Freedland SJ, Humphreys EB, Mangold LA, et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA. 2005; 294: 433439.
  • 4
    Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. NEngl J Med. 2005; 352: 19771984.
  • 5
    D'Amico AV, Chen MH, Roehl KA, Catalona WJ. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med. 2004; 351: 125135.
  • 6
    D'Amico AV, Renshaw AA, Sussman B, Chen MH. Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy. JAMA. 2005; 294: 440447.
  • 7
    Thompson IM, Ankerst DP, Chi C, et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst. 2006; 98: 529534.
  • 8
    Carter HB, Pearson JD, Metter EJ, et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA. 1992; 267: 22152220.
  • 9
    Smith DS, Catalona WJ. Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection. J Urol. 1994; 152: 1163117.
  • 10
    Pinsky PF, Andriole G, Crawford ED, et al. Prostate-specific antigen velocity and prostate cancer Gleason grade and stage. Cancer. 2007; 109: 16891695.
  • 11
    Sun L, Gancarczyk K, Paquette EL, et al. Introduction to Department of Defense Center for Prostate Disease Research Multicenter National Prostate Cancer Database, and analysis of changes in the PSA-era. Urol Oncol. 2001; 6: 203209.
  • 12
    Gleason DF, Group VACUR. Histologic grading and staging of prostatic carcinoma. In: TannenbaumM, ed. Urologic Pathology. Philadelphia, Pa: Lea & Febiger; 1977: 171187.
  • 13
    Punglia RS, D'Amico AV, Catalona WJ, Roehl KA, Kuntz KM. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med. 2003; 349: 335342.
  • 14
    Simultaneous inferences and other topics in regression analyses-1. In: KutnerM, ed. Applied Linear Regression Models. Homewood, Ill: Richard D. Irwin; 1983: 150153.
  • 15
    Llorente MD, Burke M, Gregory GR, et al. Prostate cancer: a significant risk factor for late-life suicide. Am J Geriatr Psychiatry. 2005; 13: 195201.